Lung In Vitro Model Market Revenue, Region, Country, and Segment Analysis & Sizing For 2028

global lung in vitro model market size is expected to reach USD 976.9 Million in 2028 and register a CAGR of 17.9%, according to the latest report by Reports and Data.



Increasing investments in research and development activities and rising funds for research by government and private organizations are key factors boosting global market growth 

The global lung in vitro model market size is expected to reach USD 976.9 Million in 2028 and register a CAGR of 17.9%, according to the latest report by Reports and Data. Advancements in cell culturing technology, high preference for in vitro models instead of animal models, introduction of new 3D in vitro models, and increasing prevalence of lung disorders and lung cancer are key factors driving global market revenue growth. 

Lungs are one of the important organs in the human body. Dysfunction in lungs affects the structure and functioning that can cause lethal effects. Though animal models are prevalently used for drug screening, introduction of better alternatives to minimize experiments on animals is boosting demand for in vitro models. Rising prevalence of lung diseases like asthma, lung cancer, Idiopathic Pulmonary Fibrosis (IPF), Chronic Obstructive Pulmonary Disease (COPD), and stringent regulations regarding animal experimenting is boosting global market growth. In addition, increasing adoption of 3D cell culture, introduction of advanced 3D in vitro models, and increasing research activities on lung disorders are supporting growth of the global lung in vitro model market. High usage of in vitro models in contract research organizations, pharmaceuticals and biotechnology companies, and other research institutes is also fueling market revenue growth. 

Get a sample of the report @

The rapid adoption of AI, ML, and IoT and robust data management processes has made the hospitals and clinical settings smarter. New technologies and solutions have improved the normal medical processes such as clinical diagnosis, treatment, diseases management, and monitoring patient recovery after discharge. Rapid digitalization and increasing adoption of virtual care and telemedicine is further expected to positively impact the revenue growth of the market going ahead.

Emergence of new healthcare and telemedicine startups, increasing number of collaborations among healthcare facilities and research institutions, and rising focus on patient engagement solutions has further fueled revenue growth of the market. Key companies are forming strategic alliances and collaborative ventures such as mergers and acquisitions, joint ventures, partnerships, manufacturing and licensing agreements, and product launches among others.

Order this report @

Leading Players Analyzed in the Report:

Epithelix, MatTek Corporation, Lonza, ATCC, InSphero, Emulate, AlveoliX, Oncotheis, Thermo Fischer Scientific Inc., PromoCell GmbH, Merck KGaA, TissUse, Mimetas, and CN Bio Innovations 

Furthermore, to offer a better understanding of the competitive landscape, an extensive SWOT analysis and Porter’s Five Forces analysis are included in the report. Along with this, feasibility analysis and investment return analysis are also covered in the report.

The report further discusses in detail the regional spread of the global Lung In Vitro Model market along with analysis of production and consumption patterns, import/export analysis, supply and demand ratio, market share and size based on volume and value, trends and demands, revenue share, and presence of the key players of the market.

Key Regions Studied in the Report:

  • North America (U.S., Canada, Mexico)
  • Europe (U.K., Italy, Germany, France, Rest of Europe)
  • Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
  • Latin America (Chile, Brazil, Argentina, Rest of Latin America)
  • Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

 Segmentation based on Types:

Based On Type: (Revenue, USD Million, 2018 - 2028)

  • 2D Models
  • 3D Models
  • In-house 3D Models
  • Commercialized 3D Models

Based On Application: (Revenue, USD Million, 2018 - 2028)

  • Drug Discovery
  • Toxicology
  • 3D Model Development
  • Basic Research
  • Physiological Research
  • Stem Cell Research and Regenerative Medicine

Request a customization of the report @

Thank you for reading our report. To know more about the customization of the report or further query about the report, please get in touch with us. Our team will ensure the report is well suited to your requirements. 

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:       

John W

Head of Business Development

Reports and Data | Web:

Direct Line: +1-212-710-1370